Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy
Dyslipidemia is one of the most important risk factors for the development of vascular damage in people with type 2 diabetes. For primary and secondary prevention of cardiovascular diseases, blood lipid levels should therefore be checked, especially in people with type 2 diabetes (NVL 2023, Mach et al. 2019).
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
In 2010, 33.0% of the 45- to 79-year-old people with known type 2 diabetes achieve the target of Non-HDL-Cholesterol of < 130 mg/dl. Men (40.3%) reach the target for Non-HDL-Cholesterol more frequently compared to women (24.7%). No differences are shown for age, education and region. While in 1998 7.7% of people with type 2 diabetes aged 45-79 years reach the Non-HDL-Cholesterol therapy goal, this proportion is a significantly higher in 2010 (33.0%).
In 2010, only a third of the 45-79-year-olds with type 2 diabetes meets the cholesterol target for Non-HDL-Cholesterol. Notably less women than men achieve the cholesterol target, which could be due to the fact that women use less statins than men (Du et al., 2019). However, between 1998 and 2010, a significant improvement in cholesterol target attainment was observed (Du et al., 2015). Nevertheless, the cholesterol target still falls short of the guideline-based recommendations.